Opioid overdose decedent characteristics during COVID-19
Annals of Medicine, 2022 Introduction Alongside the emergence of COVID-19 in the United States, several reports highlighted increasing rates of opioid overdose from preliminary data.
Gian-Gabriel P. Garcia +6 more
doaj +2 more sources
Opioid overdose crises during the COVID-19 pandemic: implication of health disparities
Harm Reduction Journal, 2021 Background Recent data suggest a disproportionate impact of opioid overdoses on Black Americans. The study aims to describe emergency department (ED) visits at a Southern, urban ED pertaining to opioid overdose and associated health disparities.
Ishika Patel, Lauren A. Walter, Li Li
doaj +2 more sources
Morbidity and Mortality Weekly Report, 2021 Deaths involving synthetic opioids other than methadone (synthetic opioids), which largely consist of illicitly manufactured fentanyl; psychostimulants with abuse potential (e.g., methamphetamine); and cocaine have increased in recent years, particularly
C. Mattson +5 more
semanticscholar +3 more sources
Examining rural community pharmacists’ knowledge and practices in opioid overdose prevention and treatment services in the Southeastern United States [PDF]
Harm Reduction JournalBackground Rural communities often face higher rates of opioid-related harm but fewer resources to address risk. Pharmacies in these areas are critical for opioid overdose prevention and treatment for opioid use disorder (OUD) as they may serve as ...
Stefanie P. Ferreri +4 more
doaj +2 more sources
Opioid overdose and naloxone administration knowledge and perceived competency in a probability sample of Indiana urban communities with large Black populations. [PDF]
PLoS ONEBackgroundOpioid overdose deaths pose a serious public health concern in the United States, with disproportionately higher rates of increase among Black Americans despite expanded naloxone access.
Shin Hyung Lee +5 more
doaj +2 more sources
The NOD (Naltrexone for Overdose Prevention) study protocol: a pilot randomized controlled trial of intramuscular naltrexone for opioid overdose prevention among people who use stimulants living with or at risk for HIV [PDF]
Addiction Science & Clinical PracticeBackground Drug-related mortality in the United States continues to transform, marked by a surge in overdose deaths involving both fentanyl and stimulants.
Ayesha Appa +8 more
doaj +2 more sources
Drug and Alcohol Dependence Reports, 2022 Background: Naloxone distributed to people at risk for opioid overdose has been associated with reduced overdose death rates; however, associations of retail pharmacy-distributed naloxone with overdose mortality have not been evaluated.
Jake R. Morgan +10 more
doaj +1 more source
International Journal of Population Data Science, 2022 Objectives There are critical periods of mortality risk at onset and cessation of opioid agonist treatment. We aim to determine whether non-fatal overdose followed the same pattern as fatal overdose, comparing the first 4 weeks of treatment and ...
Nicola Jones +6 more
doaj +1 more source
The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis
Current Opinion in Psychiatry, 2021 Purpose of review This review provides an update on recently published literature on the rise of illicit fentanyls, risks for overdose, combinations with other substances, e.g. stimulants, consequences, and treatment.
D. Ciccarone
semanticscholar +1 more source
Annals of Medicine, 2022 Introduction Implementing public health vending machines (PHVMs) is an evidence-based strategy for mitigating substance use-associated morbidity and mortality via the dispensation of essential supplies to people who use drugs, including overdose ...
Sean T. Allen +9 more
doaj +1 more source